Urolita - Company finances
|
EUR
|
2019
From: 2019-03-05
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 23,830 | 69,960 | 67,060 | 61,680 | 109,740 | 118,910 | 211,070 |
| Profit before tax | 16,949 | 44,720 | 40,451 | 34,613 | 65,478 | 78,160 | 155,164 |
| Net profit | 16,102 | 42,484 | 38,414 | 32,806 | 62,114 | 74,217 | 145,727 |
| Equity | 16,202 | 58,686 | 67,201 | 45,007 | 67,121 | 44,975 | 64,827 |
| Liabilities | - | - | - | 3,709 | 4,742 | 6,418 | 14,474 |
| Non-current assets | 2,756 | 2,847 | 8,861 | 10,293 | 7,092 | 10,437 | 31,871 |
| Current assets | 14,898 | 61,920 | 63,324 | 38,423 | 64,771 | 40,956 | 47,317 |
| Total assets | 17,654 | 64,767 | 72,185 | 48,716 | 71,863 | 51,393 | 79,188 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 5,932 | 7,661 | 7,433 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | +193.6% | -4.1% | -8.0% | +77.9% | +8.4% | +77.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 91.2% | 65.6% | 53.2% | 67.3% | 86.4% | 144.4% | 184.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 99.4% | 72.4% | 57.2% | 72.9% | 92.5% | 165.0% | 224.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 67.6% | 60.7% | 57.3% | 53.2% | 56.6% | 62.4% | 69.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 71.1% | 63.9% | 60.3% | 56.1% | 59.7% | 65.7% | 73.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 0.1 | 0.1 | 0.1 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | 109,740 | 118,910 | 211,070 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Urolita - Social security debts
The amount of overdue SODRA debt for the company Urolita as of the last working day is: 0 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-15 | 0.04 |
| 2026-08-26 | 2026-09-02 | 0.04 |
| 2026-08-23 | 2026-08-23 | 0.04 |
| 2026-08-19 | 2026-08-19 | 0.04 |
| 2026-08-16 | 2026-08-17 | 0.04 |
| 2026-05-03 | 2026-08-14 | 0.04 |
| 2025-12-16 | 2026-04-30 | 0.04 |
| 2025-10-23 | 2025-11-13 | 0.04 |
| 2025-10-16 | 2025-10-22 | 0.02 |
| 2025-09-07 | 2025-10-14 | 0.02 |
| 2025-08-31 | 2025-09-03 | 0.02 |
| 2025-08-19 | 2025-08-29 | 0.02 |
| 2025-07-16 | 2025-08-13 | 0.02 |
| 2025-06-17 | 2025-07-14 | 0.02 |
| 2025-06-11 | 2025-06-12 | 0.02 |
| 2025-06-08 | 2025-06-09 | 0.02 |
| 2025-05-16 | 2025-06-04 | 0.02 |
| 2025-05-04 | 2025-05-13 | 0.02 |
| 2025-04-24 | 2025-04-29 | 0.02 |
| 2024-06-03 | 2024-06-03 | 1047.00 |
| 2024-05-30 | 2024-06-02 | 982.50 |
| 2024-05-16 | 2024-05-29 | 1046.20 |
| 2024-05-15 | 2024-05-15 | 982.60 |
| 2024-05-02 | 2024-05-06 | 63.70 |
| 2024-04-03 | 2024-04-07 | 63.70 |
| 2024-03-01 | 2024-03-14 | 63.70 |
| 2024-02-01 | 2024-02-04 | 63.70 |
| 2024-01-16 | 2024-01-16 | 116.46 |
| 2024-01-15 | 2024-01-15 | 52.86 |
| 2024-01-03 | 2024-01-11 | 101.74 |
| 2023-12-18 | 2024-01-02 | 43.11 |
| 2023-12-01 | 2023-12-14 | 43.41 |
| 2023-06-01 | 2023-06-12 | 0.04 |
| 2023-05-02 | 2023-05-08 | 0.04 |
| 2023-04-25 | 2023-04-28 | 0.04 |
| 2023-03-16 | 2023-03-16 | 50.95 |
| 2023-02-21 | 2023-03-12 | 50.95 |
| 2023-02-17 | 2023-02-20 | 78.60 |
| 2023-02-06 | 2023-02-16 | 50.95 |
| 2022-11-03 | 2023-02-03 | 50.95 |
| 2022-10-03 | 2022-10-31 | 50.95 |
| 2022-08-02 | 2022-09-30 | 50.95 |
Urolita - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-29 | 2026-04-01 | 0.17 |
| 2026-02-28 | 2026-03-27 | 0.17 |
| 2026-02-03 | 2026-02-21 | 0.17 |
| 2026-01-01 | 2026-02-02 | 0.12 |
| 2025-11-02 | 2025-11-14 | 1.17 |
| 2025-10-02 | 2025-11-01 | 0.87 |
| 2025-09-30 | 2025-10-01 | 0.29 |
| 2025-09-28 | 2025-09-29 | 61.33 |
| 2025-09-19 | 2025-09-25 | 61.33 |
| 2025-07-16 | 2025-07-25 | 0.75 |
| 2025-06-28 | 2025-07-15 | 0.04 |
| 2025-06-19 | 2025-06-25 | 0.04 |
| 2025-06-17 | 2025-06-18 | 0.1 |
| 2025-05-17 | 2025-05-20 | 56.26 |
| 2025-05-01 | 2025-05-16 | 164.67 |
| 2025-04-30 | 2025-04-30 | 0.17 |
| 2025-03-28 | 2025-04-14 | 0.57 |
| 2025-03-16 | 2025-03-20 | 0.58 |
| 2025-03-15 | 2025-03-15 | 16.9 |
| 2025-02-02 | 2025-02-17 | 0.16 |
| 2024-11-01 | 2024-11-25 | 3.36 |
| 2024-10-16 | 2024-10-31 | 2.73 |
| 2024-10-01 | 2024-10-15 | 3.25 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Urolita, MB (code 305060591) is a Small partnership active in medical specialists activities. In 2025, the company generated revenue of €211.1K, up from €118.9K in 2024 and €109.7K in 2023, showing a strong two-year growth trend. Net profit increased to €145.7K in 2025 from €74.2K in 2024 and €62.1K in 2023, while the profit margin improved to 69.0% from 62.4% and 56.6% in the prior years. This indicates that profitability strengthened alongside expanding turnover. The 2025 balance sheet shows total assets of €79.2K, equity of €64.8K and liabilities of €14.5K. The equity ratio stood at 81.9%, and debt-to-equity was 0.22, pointing to a conservative capital structure. Asset turnover reached 2.67x, reflecting efficient use of the asset base. Return on equity was 224.8% and return on assets 184.0%, supported by the company’s high profitability relative to its balance sheet size. Revenue per employee was €211.1K and profit per employee €145.7K in 2025, suggesting strong productivity.